​
​

Carmell Therapeutics Ownership | Who Owns Carmell Therapeutics?

OverviewRevenueFinancialsChart

Carmell Therapeutics Ownership Summary

Carmell Therapeutics is owned by 63.76% institutional investors, and 36.24% retail investors. The Merger Fund A is the top mutual fund, with 2.15% of its assets in Carmell Therapeutics shares.

ALPA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCarmell Therapeutics63.76%-36.24%
SectorFinancial Services Stocks 43.07%12.53%44.40%
IndustryShell Companies Stocks 29.08%16.44%54.49%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202333-13.16%12,605,431-2.88%631.48%1440.00%3-50.00%
Mar 31, 202338-12,979,4161.00%651.55%1066.67%6-25.00%
Dec 31, 202238-2.56%12,850,8990.13%651.54%6-57.14%8166.67%
Sep 30, 20223918.18%12,834,3396.36%641.74%1427.27%350.00%
Jun 30, 20223322.22%12,066,4991.69%611.69%1157.14%2100.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
The Merger Fund A425.25K2.15%217.77K
Picton Mahoney Fortified Arbtrg Pl Alt F390.80K1.98%-
Virtus Westchester Event-Driven Fd I42.08K0.21%23.57K
JNL Multi-Manager Alternative A9.48K0.05%-
JNL/Westchester Capital Event Driven A6.98K0.04%-
Karpus Conservative Balanced5.70K0.03%5.70K
The Merger Fund VL I5.15K0.03%2.65K
Karpus Tax Sensitive Fixed Income4.60K0.02%4.60K
Karpus Taxable Fixed Income2.20K0.01%2.20K
Karpus Growth Balanced1.10K0.01%1.10K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 14, 2023Cassaday Bryan J. Chief Financial OfficerBuy$1.54K
Dec 14, 2023Spenlehauer Gilles-Buy$1.13K
Dec 15, 2023Spenlehauer Gilles-Buy$2.33K
Dec 14, 2023Frisch Scott M.-Buy$1.13K
Dec 15, 2023Frisch Scott M.-Buy$2.33K

Insider Transactions Trends

DateBuySell
2023 Q453-
2023 Q315-
2021 Q3--

ALPA Ownership FAQ

Who Owns Carmell Therapeutics?

Carmell Therapeutics shareholders are primarily institutional investors at 63.76%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Carmell Therapeutics's industry, Shell Companies Stocks , is 29.08%, which Carmell Therapeutics exceeds.

Does Blackrock own Carmell Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Carmell Therapeutics.

Who is the top mutual fund holder of Carmell Therapeutics shares?

The Merger Fund A is the top mutual fund holder of Carmell Therapeutics shares, with 2.15% of its total shares outstanding invested in 425.25K Carmell Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools